The report on global cell-based assays market provides qualitative and quantitative analysis for the period of 2017 to 2023. According to report the global cell-based assays market is expected to grow at a CAGR between 8.0% and 8.5 % over the forecast period of 2017 - 2023. The global market size was USD 11.3 billion in 2015.
Figure 1: Global Cell-based Assays Market by Value 2015 - 2023
The report identified that global cell-based assays is driven by factors such as growing drug discovery activity, increasing incidence of chronic diseases, and growing preference for cell-based assays. While the restraining factors include high cost of cell-based assays deployment and instruments. Further, the report identifies the opportunities in the world market as emerging markets in Asian countries.
The report on global cell-based assays market covers the segments based on products and services, applications, and end user. The products and services of cell-based assays include instruments, consumables, software and services. The applications segment includes drug discovery, basic research, predictive toxicology, ADME studies and other applications. On the basis of end user pharmaceutical & biotechnology companies, contract research organizations, academic & government institutions and other end users.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography are provided over the period of 2017 – 2023.
Figure 2: Global Cell-based Assays Market by Region
Globally, North America market dominated the world cell-based assays market followed by Europe and Asia-Pacific. Furthermore, Asia Pacific market is expected to grow at the highest CAGR over the forecast period 2017-2023.Due to the increasing growth of cell based assays market in China, Japan, and India
The report provides profiles of the companies in the global cell-based assays market such as, Perkinelmer, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, General Electric Company, Merck KGaA, Danaher Corporation, Charles River Laboratories, Inc., Cisbio Bioassays, Promega Corporation, and Cell Biolabs Inc.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global cell-based assays market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of cell-based assays market. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the cell-based assays market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.
This report will help manufacturers, suppliers and distributors of the cell-based assays market to understand the present and future trends in this market and formulate their strategies accordingly.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter